Moberly JB - Search Results

1

Effects of peritoneal rest on peritoneal transport and peritoneal membrane thickening in continuous ambulatory peritoneal dialysis rats.

Kim YL, Kim SH, Kim JH, Kim SJ, Kim CD, Cho DK, Kim YJ, Moberly JB. Kim YL, et al. Among authors: moberly jb. Perit Dial Int. 1999;19 Suppl 2:S384-7. Perit Dial Int. 1999. PMID: 10406551

2

Intraperitoneal hyaluronan administration in conscious rats: absorption, metabolism, and effects on peritoneal fluid dynamics.

Breborowicz A, Polubinska A, Pawlaczyk K, Kuzlan-Pawlaczyk M, Moberly J, Martis L, Oreopoulos D. Breborowicz A, et al. Perit Dial Int. 2001 Mar-Apr;21(2):130-5. Perit Dial Int. 2001. PMID: 11330555

3

Effects of intraperitoneal hyaluronan on peritoneal fluid and solute transport in peritoneal dialysis patients.

Moberly JB, Sorkin M, Kucharski A, Ogle K, Mongoven J, Skoufos L, Lin L, Bailey S, Rodela H, Mupas L, Walele A, Ogrinc F, White D, Wolfson M, Martis L, Breborowicz A, Oreopoulos DG. Moberly JB, et al. Perit Dial Int. 2003 Jan-Feb;23(1):63-73. Perit Dial Int. 2003. PMID: 12691509 Clinical Trial.

4

L-2-oxothiazolidine-4-carboxylate: an agent that modulates lipopolysaccharide-induced peritonitis in rats.

Korybalska K, Wieczorowska-Tobis K, Polubinska A, Wisniewska J, Moberly J, Martis L, Breborowicz A, Oreopoulos DG. Korybalska K, et al. Perit Dial Int. 2002 May-Jun;22(3):293-300. Perit Dial Int. 2002. PMID: 12227385

5

Dialysis solution containing hyaluronan: effect on peritoneal permeability and inflammation in rats.

Połubinska A, Pawlaczyk K, Kuzlan-Pawlaczyk M, Wieczorowska-Tobis K, Chen C, Moberly JB, Martis L, Breborowicz A, Oreopoulos DG. Połubinska A, et al. Among authors: moberly jb. Kidney Int. 2000 Mar;57(3):1182-9. doi: 10.1046/j.1523-1755.2000.00946.x. Kidney Int. 2000. PMID: 10720971 Free article.

6

Alterations in lipoprotein composition in peritoneal dialysis patients.

Moberly JB, Attman PO, Samuelsson O, Johansson AC, Knight-Gibson C, Alaupovic P. Moberly JB, et al. Perit Dial Int. 2002 Mar-Apr;22(2):220-8. Perit Dial Int. 2002. PMID: 11990407

7

Dyslipidemia in peritoneal dialysis--relation to dialytic variables.

Johansson AC, Samuelsson O, Attman PO, Haraldsson B, Moberly J, Knight-Gibson C, Alaupovic P. Johansson AC, et al. Perit Dial Int. 2000 May-Jun;20(3):306-14. Perit Dial Int. 2000. PMID: 10898048

8

New developments in peritoneal dialysis solutions.

Chen CJ, Moberly JB, Martis L. Chen CJ, et al. Among authors: moberly jb. Adv Perit Dial. 1998;14:116-9. Adv Perit Dial. 1998. PMID: 10649707

9

Alterations of intraperitoneal inflammation by the addition of L-2-oxothiazolidine-carboxylate.

Korybalska K, Breborowicz A, Wieczorowska-Tobis K, Polubinska A, Moberly J, Martis L, Oreopoulos DG. Korybalska K, et al. Adv Perit Dial. 1997;13:197-200. Adv Perit Dial. 1997. PMID: 9360680

10

Pharmacokinetics of icodextrin in peritoneal dialysis patients.

Moberly JB, Mujais S, Gehr T, Hamburger R, Sprague S, Kucharski A, Reynolds R, Ogrinc F, Martis L, Wolfson M. Moberly JB, et al. Kidney Int Suppl. 2002 Oct;(81):S23-33. doi: 10.1046/j.1523-1755.62.s81.5.x. Kidney Int Suppl. 2002. PMID: 12230479 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters